Latest News

Asking those with at least five years of post-residency experience to share their ideas for reforming health care may lead to some common themes that could emerge as the basis of a health care constitution for change.

Catch up on the top radiology content of the past week.

Comparing annual emergency department encounters that involved a head CT in 2007 and 2022, researchers noted a 51 percent increase and also found significant disparities in access to head CTs for Black patients, those on Medicaid and patients in rural hospital settings.

Geared toward interventional radiologists, the Alphenix 4D CT with Aquilion One/Insight Edition combines angiography capabilities with advanced features in computed tomography.

For T3-T4 rectal cancer staging, a new study showed that optimal photon-counting CT offered an AUC range between 80 and 86 percent in comparison to an AUC range between 78 and 88 percent for rectal MRI.

The recently launched PIV Assist reportedly offers a variety of features including real-time calculation of the catheter-to-vein ratio and pre-scan differentiation of veins and arteries to facilitate vascular access planning.

The use of radiomics for mammography may help predict the development of occult invasive cancer in women with ductal carcinoma in situ (DCIS), according to a new study.

In a recent interview, Christoph Lee, M.D., discussed key findings from the ASSURE study, which evaluated the use of AI in detection and triage in a multicenter trial involving over 579,000 women who had digital breast tomosynthesis (DBT) exams.

The Synapse One platform reportedly offers a variety of enterprise imaging capabilities and may facilitate reduced third-party integration complexities and costs.

Incorporating mpMRI radiomics, clinical characteristics, deep learning and pathomic features, a multimodal model offered 82 percent and 87 percent AUCs for predicting overall survival outcomes at five years and seven years, respectively, for women treated with neoadjuvant chemotherapy for breast cancer.

The newly launched Compass AI software platform reportedly facilitates a 94 percent compliance rate for documentation of point-of-care ultrasound (POCUS) exams.

The gallium-68 radiolabeled PET imaging agent ITM-94 is currently being evaluated in a phase 1/2 trial for its utility in detecting ccRCC and differentiating indeterminate renal masses.

Photon-counting computed tomography demonstrated over 20 percent accuracy at the patient level and nearly 14 percent higher accuracy level at the vessel level in comparison to energy-integrating detector CT for detecting > 70 percent stenosis, according to a newly published study.